The Novel Regulatory Role of lncRNA-miRNA-mRNA Axis in Amyotrophic Lateral Sclerosis: An Integrated Bioinformatics Analysis

Dingsheng Liu, Xiaojia Zuo, Peng Zhang, Rui Zhao, Donglin Lai, Kaijie Chen, Yuru Han, Guoqing Wan, Yanjun Zheng, Changlian Lu, Xuefeng GuComput. Math. Methods Medicine 2021 · DOI

TL;DR

This study investigates the complex regulatory network underlying Amyotrophic Lateral Sclerosis (ALS) by constructing a novel lncRNA-miRNA-mRNA competing endogenous RNA (ceRNA) network. They identified MALAT1 as a key long non-coding RNA (lncRNA) that may play a significant role in ALS pathogenesis by regulating a specific set of genes involved in crucial cellular processes.

What Problem Does This Paper Address?

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive death of motor neurons, leading to muscle atrophy and paralysis. Despite its severe impact, the precise molecular mechanisms driving ALS pathogenesis remain largely unknown. While genetics and immune responses are implicated, a comprehensive understanding of the regulatory pathways, particularly those involving non-coding RNAs, is lacking. This paper aims to bridge this gap by exploring the intricate interactions between long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) in ALS, focusing on the competing endogenous RNA (ceRNA) hypothesis.

Methods

The researchers employed a multi-pronged bioinformatics approach:

  • ceRNA Network Construction: They integrated data from the IncBase and miRTarBase databases to identify potential miRNA-lncRNA and miRNA-mRNA regulatory relationships. A hypergeometric test was used to filter for significant lncRNA-mRNA interactions based on shared target miRNAs.
  • Expression Data Analysis: RNA-sequencing data from ALS patients and control samples were analyzed to identify differentially expressed genes.
  • Protein-Protein Interaction (PPI) Network Analysis: The STRING database and Cytoscape software were used to construct and visualize PPI networks of the identified genes, allowing for the identification of key protein complexes and modules.
  • Gene Ontology (GO) and Pathway Enrichment Analysis: Metascape was utilized to analyze the functional enrichment of genes within the ceRNA and PPI networks, revealing associated biological processes and pathways.

Datasets

  • RNA-seq Data: Peripheral blood mononuclear cell RNA-seq data from 7 ALS patients and 4 control samples (GSE115259) were downloaded from the Gene Expression Omnibus (GEO) database.
  • miRNA-lncRNA Regulatory Data: The IncBase database was used to obtain miRNA-lncRNA regulatory pairs.
  • miRNA-mRNA Regulatory Data: The miRTarBase database was used to obtain miRNA-mRNA target relationships.

Key Insights and Ideas

  • ceRNA Hypothesis in ALS: The study provides strong evidence for the involvement of the ceRNA network in ALS pathogenesis, highlighting how lncRNAs can act as "sponges" to regulate miRNA activity, thereby influencing mRNA expression.
  • MALAT1 as a Key Regulator: The lncRNA MALAT1 emerged as a significant player, regulating a substantial number of genes in ALS patients. This suggests MALAT1 could be a central hub in the ALS regulatory network.
  • Functional Significance of MALAT1 Targets: Genes regulated by MALAT1 were enriched in pathways directly relevant to ALS, such as autophagy, protein targeting to vacuoles, and NF-κB signaling. This provides a mechanistic link between MALAT1 and disease progression.
  • Identification of a Novel PPI Module: A specific protein-protein interaction (PPI) module, comprising SYNRG, ITSN2, AAK1, PICALM, and AP3B1, was identified as potentially crucial in ALS pathogenesis. Notably, these genes are all regulated by MALAT1.
  • Potential for Diagnostic and Therapeutic Targets: The identification of specific lncRNAs, miRNAs, and their target genes offers potential avenues for developing diagnostic biomarkers and therapeutic strategies for ALS.

Key Results

  • 247,177 potential lncRNA-mRNA ceRNA relationship pairs were initially screened.
  • MALAT1 was found to regulate 75 genes in ALS samples.
  • RP11-631N16.2 regulated 137 genes in control samples.
  • GO analysis of MALAT1-regulated genes in ALS revealed enrichment for terms like protein targeting to vacuole, vesicle organization, and NF-κB signaling pathway.
  • A PPI module formed by SYNRG, ITSN2, AAK1, PICALM, and AP3B1 was highlighted as potentially important in ALS.

Limitations and Future Work

  • In vitro/in vivo validation needed: The study is based on bioinformatics analysis. The identified regulatory relationships and their functional significance require experimental validation through in vitro and in vivo studies.
  • Focus on specific datasets: The analysis was performed on peripheral blood mononuclear cells. Investigating other tissue types, such as spinal cord tissue, could provide a more direct understanding of motor neuron pathology.
  • Further investigation of identified genes: While MALAT1 and the PPI module genes are highlighted, further research is needed to fully elucidate their precise roles and interactions in ALS pathogenesis. The authors suggest that further research is warranted to determine if the other four genes in the identified module are indeed related to ALS.
  • Exploring other lncRNAs: While MALAT1 is a key finding, other lncRNAs may also play significant roles in ALS and warrant similar investigation.

Summary updated

BibTeX
@article{liu2021novel,
  author = {Dingsheng Liu and Xiaojia Zuo and Peng Zhang and Rui Zhao and Donglin Lai and Kaijie Chen and Yuru Han and Guoqing Wan and Yanjun Zheng and Changlian Lu and Xuefeng Gu},
  title = {{The Novel Regulatory Role of lncRNA-miRNA-mRNA Axis in Amyotrophic Lateral Sclerosis: An Integrated Bioinformatics Analysis}},
  journal = {Comput. Math. Methods Medicine},
  year = {2021},
  doi = {10.1155/2021/5526179},
}
Figure